Article Information
History
- December 13, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Joseph H. Lubin1,*,
- Christopher Markosian2,3,*,
- D. Balamurugan4,
- Renata Pasqualini2,3,
- Wadih Arap2,5,
- Stephen K. Burley1,6,7,8,9 and
- Sagar D. Khare1,8,9,10
- 1Department of Chemistry and Chemical Biology, Rutgers, The State University of New Jersey, Piscataway, NJ 08854
- 2Rutgers Cancer Institute of New Jersey, Newark, NJ 07101
- 3Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ 07103
- 4Office of Advanced Research Computing, Rutgers, The State University of New Jersey, Piscataway, NJ 08854
- 5Division of Hematology/Oncology, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103
- 6RCSB Protein Data Bank, Rutgers, The State University of New Jersey, Piscataway, NJ 08854
- 7RCSB Protein Data Bank, San Diego Supercomputer Center and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92067
- 8Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08901
- 9Institute for Quantitative Biomedicine, Rutgers, The State University of New Jersey, Piscataway, NJ 08854
- ↵10Corresponding Author, Email: khare{at}chem.rutgers.edu
↵* Equal contribution
Posted December 13, 2021.
Structural models of SARS-CoV-2 Omicron variant in complex with ACE2 receptor or antibodies suggest altered binding interfaces
